Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|December 30, 2009
Impact of different factors on the probability of clinical response in tigecycline-treated patients with intra-abdominal infectionsS M Bhavnani, C M Rubino, P G Ambrose, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2018
Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal ActivityPaul G Ambrose, Brian D VanScoy, John Adams, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
Evaluation of the pharmacokinetics and pharmacodynamics of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infections using data from two phase 2 clinical studiesOlanrewaju O Okusanya, Sujata M Bhavnani, Jeffrey P Hammel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the deadBrian T Tsuji, Olanrewaju O Okusanya, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected PatientsM Trang, D C Griffith, S M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2007
Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection modelPaul G Ambrose, Alan Forrest, William A Craig, et al.
Diagnostic Microbiology and Infectious Disease|March 24, 2000
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremiaS M Bhavnani, J A Drake, A Forrest, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2024
Population pharmacokinetic analyses for sulbactam-durlobactam using Phase 1, 2, and 3 dataAnthony P Cammarata, M Courtney Safir, Michael Trang, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2015
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection ModelBrian D VanScoy, Jennifer McCauley, Evelyn J Ellis-Grosse, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 9, 2003
Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitalsSujata M Bhavnani, Wendy A Callen, Alan Forrest, et al.
Pageof 16